Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PLCG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELK1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL22RA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC71L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf51 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INO80D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIO - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIK3R1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OCLN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAPBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYNGAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCDHA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on